Sensitivity and specificity of symptom and sign combinations for the identification of 2009 influenza A virus (H1N1) infection in patients with negative rapid influenza diagnostic tests (RIDTs).

<p>RIDT, rapid influenza diagnostic test; RT-PCR, reverse transcriptase polymerase chain reaction; AUROC, area under the receiver operating characteristic curve; LR, likelihood ratio.</p

Sensitivity and specificity of symptom and sign combinations for the identification of 2009 influenza A virus (H1N1) infection.

<p>Sensitivity and specificity of symptom and sign combinations for the identification of 2009 influenza A virus (H1N1) infection.</p

Presenting symptoms in patients with non-influenza illness and 2009 influenza A virus (H1N1) infection.

<p>Presenting symptoms in patients with non-influenza illness and 2009 influenza A virus (H1N1) infection.</p

Demographic characteristics and comorbidities in patients with non-influenza illness and 2009 influenza A virus (H1N1) infection.

<p>COPD, chronic obstructive pulmonary disease.</p

Flow chart of patient inclusion, including 226 cases of 2009 influenza A virus (H1N1) infection and 319 cases of non-influenza controls.

<p>RIDT, rapid influenza diagnostic test; RT-PCR, reverse transcriptase polymerase chain reaction.</p

Airborne adenovirus and <i>Mycoplasma pneumoniae</i> in the pediatric public areas.

<p>The monthly positive rates (mean±se) of airborne particles containing adenovirus (ADV) and <i>Mycoplasma pneumoniae</i> (MP) in the pediatric emergency room (ER) (A) and pediatric outpatient department (OPD) (B). **: <i>p</i><0.01.</p

The sequences of primers and probes of adenovirus and <i>Mycoplasma Pneumoniae.</i>

<p>The sequences of primers and probes of adenovirus and <i>Mycoplasma Pneumoniae.</i></p

Objective snoring sound parameters at baseline for the entire study cohort (<i>n</i> = 30).

<p>Values were given as mean (standard error). AHI: apnea-hypopnea index. BMI: body mass index. CI: conference interval; PSG-SI: polysomnography-defined snoring index. SOS: snoring outcomes survey. VAS: visual analogue scale.</p><p>*Statistical analyses were implemented with the Mann-Whitney <i>U</i> test.</p

Multivariable analysis of 5-year control and survival rates in OSCC patients (<i>n</i> = 58).

<p>Abbreviations: HR, hazard ratio; CI, confidence interval; ns, not significant.</p><p>* Indicates risk factors significantly associated with outcomes in univariate analysis.</p

Results of objective snoring sound parameters before and after treatment in the two groups.

<p>CI: conference interval. Fmean: mean sound frequency. Fpeak: peak sound frequency. Imax: maximal sound intensity. Imean: mean sound intensity.</p